All Stories

  1. Regulation between LRRK2 and PP2A signaling in cellular models of Parkinson’s disease
  2. Taliglucerase Alfa Reduces Amyloid-β Burden by Restoring Autophagic Pathways in a Neuronal Model of Alzheimer’s Disease
  3. Collaboration of Antipodes: Synergy of Branched and Linear F-Actin during Amoeboid Cell Movement and Chemotaxis
  4. Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase-dependent mechanism
  5. PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific manner
  6. The effects of whole-body vibration therapy on immune and brain functioning: current insights in the underlying cellular and molecular mechanisms
  7. Analysis of cGMP Signaling in Dictyostelium
  8. GRminusRD: A Sensitive Assay to Detect Activation Processes at the Plasma Membrane in Living Cells
  9. PAK6-mediated phosphorylation of PPP2R2C regulates LRRK2-PP2A complex formation
  10. Species-specific metabolic reprogramming in human and mouse microglia during inflammatory pathway induction
  11. Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization
  12. LRRK2 Structure-Based Activation Mechanism and Pathogenesis
  13. Characterization of Lipopolysaccharide Effects on LRRK2 Signaling in RAW Macrophages
  14. LRRK2 protects immune cells against erastin-induced ferroptosis
  15. C2GAP2 is a common regulator of Ras signaling for chemotaxis, phagocytosis, and macropinocytosis
  16. Component Analysis of Photon Counting Histograms in Fluorescence Fluctuation Spectroscopy Experiments
  17. The multifaceted role of LRRK2 in Parkinson's disease: From human iPSC to organoids
  18. Potential of Whole-Body Vibration in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Human and Animal Studies
  19. Editorial: LRRK2—Fifteen Years From Cloning to the Clinic
  20. A Phosphosite Mutant Approach on LRRK2 Links Phosphorylation and Dephosphorylation to Protective and Deleterious Markers, Respectively
  21. The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation
  22. Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2
  23. The beneficial effect of salubrinal on neuroinflammation and neuronal loss in intranigral LPS-induced hemi-Parkinson disease model in rats
  24. Forty-five years of cGMP research in Dictyostelium: understanding the regulation and function of the cGMP pathway for cell movement and chemotaxis
  25. Allosteric Inhibition of Parkinson’s-Linked LRRK2 by Constrained Peptides
  26. A Conserved Role for LRRK2 and Roco Proteins in the Regulation of Mitochondrial Activity
  27. Membrane Targeting of C2GAP1 Enables Dictyostelium discoideum to Sense Chemoattractant Gradient at a Higher Concentration Range
  28. LRRK2 Targeting Strategies as Potential Treatment of Parkinson’s Disease
  29. Combined FCS and PCH Analysis to Quantify Protein Dimerization in Living Cells
  30. The tale of proteolysis targeting chimeras (PROTACs) for leucine‐rich repeat kinase 2 (LRRK2)
  31. The neuroprotective action of lenalidomide on rotenone model of Parkinson's Disease: Neurotrophic and supportive actions in the substantia nigra pars compacta
  32. Allosteric inhibition of LRRK2, where are we now
  33. Complex Analysis of Fluorescence Intensity Fluctuations of Molecular Compounds
  34. Coordinated Ras and Rac Activity Shapes Macropinocytic Cups and Enables Phagocytosis of Geometrically Diverse Bacteria
  35. Allosteric modulation of the GTPase activity of a bacterial LRRK2 homolog by conformation-specific Nanobodies
  36. Linalool attenuates oxidative stress and mitochondrial dysfunction mediated by glutamate and NMDA toxicity
  37. Structure and nucleotide-induced conformational dynamics of the Chlorobium tepidum Roco protein
  38. Roco Proteins: GTPases with a Baroque Structure and Mechanism
  39. Biochemical and kinetic properties of the complex Roco G-protein cycle
  40. The cytoskeleton regulates symmetry transitions in moving amoeboid cells
  41. The role of (auto)-phosphorylation in the complex activation mechanism of LRRK2
  42. GPCR-controlled membrane recruitment of negative regulator C2GAP1 locally inhibits Ras signaling for adaptation and long-range chemotaxis
  43. A homologue of the Parkinson’s disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover
  44. The LRR-Roc-COR module of theChlorobium tepidumRoco protein: crystallization and X-ray crystallographic analysis
  45. Role of the small GTPase Rap1 in signal transduction, cell dynamics and bacterial infection
  46. Coupled excitable Ras and F-actin activation mediates spontaneous pseudopod formation and directed cell movement
  47. The unconventional G-protein cycle of LRRK2 and Roco proteins
  48. Connecting G protein signaling to chemoattractant-mediated cell polarity and cytoskeletal reorganization
  49. Structural model of the dimeric Parkinson’s protein LRRK2 reveals a compact architecture involving distant interdomain contacts
  50. A Worldwide Competition to Compare the Speed and Chemotactic Accuracy of Neutrophil-Like Cells
  51. A Gα-Stimulated RapGEF Is a Receptor-Proximal Regulator of Dictyostelium Chemotaxis
  52. The small GTPases Ras and Rap1 bind to and control TORC2 activity
  53. Function and Regulation of Heterotrimeric G Proteins during Chemotaxis
  54. Direct Interaction between TalinB and Rap1 is necessary for adhesion of Dictyostelium cells
  55. Activation Mechanism of LRRK2 and Its Cellular Functions in Parkinson’s Disease
  56. Abstract B48: Homer3 regulates the establishment of neutrophil polarity
  57. Conformational heterogeneity of the Roc domains in C. tepidum Roc–COR and implications for human LRRK2 Parkinson mutations
  58. Structural Characterization of LRRK2 Inhibitors
  59. Homer3 regulates the establishment of neutrophil polarity
  60. Revisiting the Roco G-protein cycle
  61. Rap1-dependent pathways coordinate cytokinesis in Dictyostelium
  62. Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation
  63. The Potential of Targeting LRRK2 in Parkinson’s Disease
  64. Ras activation and symmetry breaking during Dictyostelium chemotaxis
  65. Reply to Tall et al.: Dictyostelium Ric8 does not have a chaperoning function during development and chemotaxis
  66. Dictyostelium Ric8 is a nonreceptor guanine exchange factor for heterotrimeric G proteins and is important for development and chemotaxis
  67. Simple system – substantial share: The use of Dictyostelium in cell biology and molecular medicine
  68. Daydreamer, a Ras effector and GSK-3 substrate, is important for directional sensing and cell motility
  69. GxcC connects Rap and Rac signaling during Dictyostelium development
  70. Roco kinase structures give insights into the mechanism of Parkinson disease-related leucine-rich-repeat kinase 2 mutations
  71. Dictyostelium discoideum: A Model System to Study LRRK2-Mediated Parkinson Disease
  72. Multiple Regulatory Mechanisms for theDictyosteliumRoco Protein GbpC
  73. Dictyostelium chemotaxis: essential Ras activation and accessory signalling pathways for amplification
  74. A Rap/Phosphatidylinositol 3-Kinase Pathway Controls Pseudopod Formation
  75. Intramolecular Activation Mechanism of theDictyosteliumLRRK2 Homolog Roco Protein GbpC
  76. Highlighting the role of Ras and Rap during Dictyostelium chemotaxis
  77. Structure of the Roc–COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase
  78. Phospholipase C Regulation of Phosphatidylinositol 3,4,5-trisphosphate-mediated Chemotaxis
  79. Essential role of PI3-kinase and phospholipase A2 inDictyostelium discoideumchemotaxis
  80. Chemoattractants and chemorepellents act by inducing opposite polarity in phospholipase C and PI3-kinase signaling
  81. Cyclic AMP signalling in Dictyostelium: G-proteins activate separate Ras pathways using specific RasGEFs
  82. Regulation of Phagocytosis in Dictyostelium by the Inositol 5-Phosphatase OCRL Homolog Dd5P4
  83. SevenDictyostelium discoideumphosphodiesterases degrade three pools of cAMP and cGMP
  84. Characterization of the GbpD-activated Rap1 Pathway Regulating Adhesion and Cell Polarity inDictyostelium discoideum
  85. DdPDE4, a Novel cAMP-specific Phosphodiesterase at the Surface of Dictyostelium Cells
  86. Phosducin-like proteins in Dictyostelium discoideum: implications for the phosducin family of proteins